Rallybio

J&J, Rallybio partner on drug development for rare fetal condition
BioPharma Dive
Wed, 04/10/24 - 06:01 pm
JNJ
Rallybio
FNAIT
drug development
Rallybio, AbCellera partner to develop therapeutics for rare diseases
Pharmaceutical Business Review
Fri, 12/2/22 - 10:54 am
Rallybio
AbCellera
Rare Diseases
drug discovery
As Sanofi prunes pipeline, ex-Alexion crew at Rallybio picks up anemia drug
Endpoints
Tue, 05/10/22 - 10:56 am
Sanofi
Rallybio
KY1066
RLYB331
Kymab
anemia
Three Biopharma Companies Made Public Debut on Nasdaq Exchange
BioSpace
Thu, 07/29/21 - 10:59 pm
IPOs
Nuvalent
Rallybio
Icosavax
NASDAQ
Rallybio hits high gear as it targets $100M IPO to fund treatments for rare fetal bleeding disorder
Fierce Biotech
Tue, 07/6/21 - 10:51 am
Rallybio
IPO
Martin Mackay’s rare disease startup gets $145 million as it enters the clinic
Endpoints
Tue, 05/19/20 - 10:42 am
Martin Mackay
Alexion
rare disease
Rallybio
FNAIT